Cargando…

Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana

BACKGROUND: HIV-1 is endemic in Botswana. The country’s primary challenge is identifying people living with HIV who are unaware of their status. We evaluated factors associated with undiagnosed HIV infection using HIV-1 phylogenetic, behavioural, and demographic data. METHODS: As part of the Botswan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhebhe, Lynnette, Moyo, Sikhulile, Gaseitsiwe, Simani, Pretorius-Holme, Molly, Yankinda, Etienne K., Manyake, Kutlo, Kgathi, Coulson, Mmalane, Mompati, Lebelonyane, Refeletswe, Gaolathe, Tendani, Bachanas, Pamela, Ussery, Faith, Letebele, Mpho, Makhema, Joseph, Wirth, Kathleen E., Lockman, Shahin, Essex, Max, Novitsky, Vlad, Ragonnet-Cronin, Manon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420270/ https://www.ncbi.nlm.nih.gov/pubmed/36031617 http://dx.doi.org/10.1186/s12879-022-07698-4

Ejemplares similares

Self-reported risky sexual practices among adolescents and young adults in Botswana
por: Chakalisa, Unoda, et al.
Publicado: (2019)

High Prevalence of Hepatitis B Virus Infection Among People With HIV in Rural and Periurban Communities in Botswana
por: Phinius, Bonolo B, et al.
Publicado: (2023)

Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015
por: Moyo, Sikhulile, et al.
Publicado: (2018)

Health impact and cost-effectiveness of HIV testing, linkage, and early antiretroviral treatment in the Botswana Combination Prevention Project
por: Resch, Stephen C., et al.
Publicado: (2022)

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
por: Bareng, Ontlametse T., et al.
Publicado: (2022)

Undetectable proviral deoxyribonucleic acid in an adolescent perinatally infected with human immunodeficiency virus-1C and on long-term antiretroviral therapy resulted in viral rebound following antiretroviral therapy termination: A case report with implications for clinical care
por: Koofhethile, Catherine Kegakilwe, et al.
Publicado: (2019)

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2019)

Acceptability of oral HIV self-testing among female sex workers in Gaborone, Botswana
por: Shava, Emily, et al.
Publicado: (2020)

Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana
por: Shava, Emily, et al.
Publicado: (2021)

Deciphering Multiplicity of HIV-1C Infection: Transmission of Closely Related Multiple Viral Lineages
por: Novitsky, Vlad, et al.
Publicado: (2016)

Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial – BCPP/Ya Tsie trial
por: Magosi, Lerato E, et al.
Publicado: (2022)

Prevalence and control of hypertension in a high HIV-prevalence setting, insights from a population based study in Botswana
por: Mosepele, Mosepele, et al.
Publicado: (2023)

To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach
por: Lebelonyane, Refeletswe, et al.
Publicado: (2021)

Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use
por: Maruapula, Dorcas, et al.
Publicado: (2023)

HIV-1 Subtype C Drug Resistance Mutations in Heavily Treated Patients Failing Integrase Strand Transfer Inhibitor-Based Regimens in Botswana †
por: Seatla, Kaelo K., et al.
Publicado: (2021)

Increasing knowledge of HIV status in a country with high HIV testing coverage: Results from the Botswana Combination Prevention Project
por: Alwano, Mary Grace, et al.
Publicado: (2019)

The impact of free antiretroviral therapy for pregnant non‐citizens and their infants in Botswana
por: Fennell, Christina, et al.
Publicado: (2023)

Estimated age and gender profile of individuals missed by a home-based HIV testing and counselling campaign in a Botswana community
por: Novitsky, Vlad, et al.
Publicado: (2015)

Identifying Recent HIV Infections: From Serological Assays to Genomics
por: Moyo, Sikhulile, et al.
Publicado: (2015)

Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana
por: Shava, Emily, et al.
Publicado: (2023)

A1 Pairwise diversity and tMRCA as potential markers of HIV infection recency
por: Moyo, Sikhulile, et al.
Publicado: (2018)

Pairwise diversity and tMRCA as potential markers for HIV infection recency
por: Moyo, Sikhulile, et al.
Publicado: (2017)

Prevalence and molecular characterization of Hepatitis B in HIV infected individuals in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2014)

Findings of a Nationwide Mixed-Methods Assessment of Cancer Care and Prevention Needs in Botswana
por: Sharma, Kirthana, et al.
Publicado: (2022)

Prediction of Coreceptor Tropism in HIV-1 Subtype C in Botswana
por: Kotokwe, Kenanao, et al.
Publicado: (2023)

High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana
por: Baruti, Kabo, et al.
Publicado: (2023)

HIV-1C in-House RNA-Based Genotyping Assay for Detection of Drug Resistance Mutations in Samples with Low-Level Viral Loads
por: Bareng, Ontlametse T, et al.
Publicado: (2022)

Abacavir alters the transcription of inflammatory cytokines in virologically suppressed, HIV-infected women
por: MacLeod, Iain J, et al.
Publicado: (2012)

In Silico Analysis of Hepatitis B Virus Occult Associated Mutations in Botswana Using a Novel Algorithm
por: Anderson, Motswedi, et al.
Publicado: (2018)

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
por: Zash, Rebecca, et al.
Publicado: (2018)

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
por: Maseng, Monkgomotsi J., et al.
Publicado: (2022)

Predicted broadly neutralizing antibody (bnAb) resistance and associated envelope characteristics of adults with HIV-1 seroconversion in Botswana
por: Moraka, Natasha Onalenna, et al.
Publicado: (2023)

Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP)
por: Marukutira, Tafireyi, et al.
Publicado: (2019)

Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2016)

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana
por: Ryan, Kathleen, et al.
Publicado: (2017)

HIV-exposed children account for more than half of 24-month mortality in Botswana
por: Zash, Rebecca, et al.
Publicado: (2016)

Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana
por: Ragonnet-Cronin, Manon, et al.
Publicado: (2021)

Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study
por: Bhebhe, Lynnette, et al.
Publicado: (2019)

Immunohaematological reference values for HIV-negative healthy adults in Botswana
por: Mine, Madisa, et al.
Publicado: (2011)

Molecular Characterization of Near Full-Length Genomes of Hepatitis B Virus Isolated from Predominantly HIV Infected Individuals in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n7ba21m21f5kcg7104458o3hfb